Home Zacks Investment Research Downgrades Bayer AG (BAYRY) to Hold
 

Keywords :   


Zacks Investment Research Downgrades Bayer AG (BAYRY) to Hold

2016-01-18 23:52:21| Biotech - Topix.net

According to Zacks, "Bayer's revenues during the third quarter of 2015 were boosted by its newly launched pharmaceutical products. These products are expected to continue their strong run in the upcoming quarters as well.

Tags: research hold investment bayer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
13.06Eastern North Pacific Tropical Weather Outlook
13.06Atlantic Tropical Weather Outlook
13.06PCI Announces 2024 Scholarship Recipients
13.06Evonik Develops TEGO Therm Fire-Resistant Coatings for EVs
13.06Suzano Acquires 15% Stake in Lenzing
13.06Ontex Plans Restructuring in Belgium
13.06Printing United Alliance and Stahls partner for education
13.06Catapult Print extends commitment to Bellissima DMS
More »